Anicor is the trade name and generic name for Paianprilizumab Injection, with side effects such as hypothyroidism, rash, and elevated aminotransferases. Paianprilizumab is a humanized immunoglobulin Gl monoclonal antibody used for relapsed or refractory atypical Hodgkin’s lymphoma. Its side effects include hypothyroidism, rash, elevated aminotransferase, anemia, decreased platelet count, decreased neutrophil count, lung infection, fever, skeletal muscle pain, hyperlipidemia, hematuria, and hypotension. Note that it is contraindicated in patients who are allergic to the product. It is not recommended for pregnant patients, and breastfeeding women should not breastfeed during administration and for at least 5 months after discontinuation of the drug. Patients must use the drug under the guidance of physicians with experience in oncology treatment and strictly comply with medical advice.